Publication Year
2022 (114 POSTS)
Campion SN, Potter DM, Bowman CJ, Catlin NR, Davis S, Millard C, Nowland WS, Stethem CM, Hollingshead BD, Radi ZA, Coder PS, Cappon GD. 2022. Lack of effects on bone growth and development following administration of tofacitinib, a JAK inhibitor, to juvenile rats and evaluation of the association between offspring growth and femur length. Reprod Toxicol 113:35–41, DOI: 10.1016/j.reprotox.2022.08.002, article online.